Pregnancy Safety Data Collection Regulation Under Review, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
A safety regulation on collecting data related to drug events in pregnant women is under review at the Office of Management & Budget.
You may also be interested in...
Pregnancy Registry Recruitment Notices Should Be Cleared - FDA Guidance
Manufacturers will need to balance the "active recruitment" strategies for pregnancy registries urged by FDA with the agency's warning that recruitment efforts must not promote use in pregnant women, a draft guidance on pregnancy registries states.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands